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tients older than men, sudden chest pain symptoms women is obvious
than men. while symptoms of irritable male more common. aortic
intramural hematoma is more common in women. Suffering from
acute type AAD women patients have higher operative mortality.
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OBJECTIVES To test whether expression of Kv4.3 in HF ventricular
myocytes would improve cardiac contraction without affecting
relaxation by inhibition of membrane associated CaMKII.
METHODS HF was generated in mice by thoracic aortic binding and
Kv4.3 was expressed in HF ventricular myocytes by left ventricular
adenoviral injection with Ad-Kv4.3 (Ad-b-gal injection was used as
control). [Ca2+]i and sarcomere length were measured by IonOptix
Ca2+ image system. Myoﬁlament sensitivity to Ca2+ was assessed
by measuring the gradient of cell length-fura2 trajectory during
contraction and late relaxation.
RESULTS HF ventricular myocytes with Kv4.3 expression presented a
signiﬁcant increase in fractional shortening and Ca2+ transient with
a reduction in diastolic SR Ca2+ leak, and a recovery of frequency-
dependent acceleration of relaxation (FDAR), an intrinsic mechanism
allowing faster ventricular relaxation and diastolic ﬁlling at fast heart
rates. In contrast to KN93, a pharmacological CaMKII inhibitor, Kv4.3
expression did not affect myoﬁlament sensitivity to Ca2+, assessed by
the changes of length-fura2 trajectory gradients. In line with this, a
phospho-Ser-antibody showed that unlike KN93, which signiﬁcantly
reduced phosphorylation in the Tn-I that co-immunoprecipitated with
CaMKII, Kv4.3 expression did not alter Tn-I phosphorylation. In vivo
study showed that Kv4.3 expression increased EF from 45  1% in HF
mice transfected with Ad-b-gal (n¼11) to 73  2% in mice transfected
with Ad-Kv4.3 (n¼10, p<0.05), while the E/E’ ratio was unchanged
(39  2 vs. 35  2, p>0.05).
CONCLUSIONS Our results suggest that Kv4.3 expression improves
myocardial contraction without detrimental effect on cardiac relaxa-
tion. Instead, it recovers FDAR.GW26-e4022
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OBJECTIVES Extracellular vesicles (EVs) participate in important
biological processes, including horizontal transfer of borne molecules
among neighboring cells. Our previous study showed the existence of
DNA in EVs that have the ability to inﬂuence the function of recipient
cells by increasing DNA-coding mRNA and protein levels. SRY (sex
determining region, Y), a gene in the Y chromosome responsible for
increasing expression of angiotensin II and noradrenaline, is associ-
ated with risk of coronary artery disease (CAD) in men. We hypothe-
size that SRY DNAs in plasma EVs is involved in the pathogenesis of
atherosclerosis by the transfer of SRY DNA to recipient cells, e.g.,
leukocytes and endothelial cells, and increased adherence of leuko-
cytes to endothelial cells.
We set out to investigate whether and how SRY (sex determining
region, Y) DNAs in plasma extracellular vesicle (EVs) is involved in the
pathogenesis of atherosclerosis.
METHODS PCR and gene sequencing found SRY gene fragment in
plasma EVs from male but not from female patients; EVs from male
patients with coronary artery disease (CAD) had higher SRY gene copy
number (GCN) than healthy subjects.
RESULTS Additional studies found that leukocytes, the major source
of plasma EVs, had higher SRY GCN and mRNA and protein expression
in male CAD patients than controls. After incubation with EVs from
SRY-transfected HEK293 cells, monocytes (THP-1) and endothelial
cells (HUVECs), which do not endogenously express SRY protein, were
found to express newly-synthesized SRY protein. This resulted in an
increase in adherence factors, CD11-a in THP-1 cells and ICAM-1 in
HUVECs. Electrophoretic mobility shift assay showed that SRY protein
increased the promoter activity of CD11-a in THP-1 cells and ICAM-1 in
HUVECs. There was an increase in THP-1 cells adherent to HUVECsafter incubation with SRY-EVs. SRY DNAs transferred from EVs have
pathophysiological signiﬁcance in vivo; injection of SRY EVs to
ApoE-/- mice accelerated atherosclerosis.
CONCLUSIONS The SRY gene in plasma EVs transferred to vascular
endothelial cells may play an important role in the pathogenesis
of atherosclerosis; this mechanism provides a new approach to the
understanding of inheritable CAD in men.
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OBJECTIVES Our studies show that deletion of the transient receptor
potential vanilloid type 1 (TRPV1) gene aggravates deoxycorticoster-
one acetate (DOCA)-salt hypertension-induced renal injury, which is
associated with increased renal monocyte chemoattractant protein-1
(MCP-1) production and monocyte/macrophage inﬁltration. The
results suggest that TRPV1 ablation-induced aggravation of renal
injury in DOCA-salt hypertension may be the result of enhanced renal
monocyte/macrophage inﬁltration that is dependent of the MCP-1/C-C
chemokine receptor 2 (CCR2) signaling pathway. Therefore, we
hypothesized that MCP-1/CCR2-mediated monocyte/macrophage
inﬁltration is a critical determinant of TRPV1 ablation-induced renal
injury in salt-sensitive hypertension.
METHODS We induced salt-sensitive hypertension for 4 weeks by
uninephrectomy and DOCA-salt in wild type (WT) and TRPV1-null
mutant (TRPV1-/-) mice with or without RS504393, a selective CCR2
antagonist.
RESULTS DOCA-salt treatment increased systolic blood pressure
(SBP) to the same degree in both strains, but increased urinary
excretion of albumin and 8-isoprostane and decreased creatinine
clearance with greater magnitude in TRPV1-/-mice compared to WT
mice (89.35.2 vs. 26.53.4 mg/24h; 4.240.45 vs. 1.520.21 ng/24h;
9819 vs. 16814 ml/24h, P<0.05). DOCA-salt treatment also caused
renal glomerulosclerosis, tubulointerstitial injury, collagen deposi-
tion, monocyte/macrophage inﬁltration, proinﬂammatory cytokine
and chemokine production, and NF-kB activation in greater degree in
TRPV1-/- mice compared to WT mice (glomerulosclerosis index:
0.780.15 vs. 0.350.14; tubulointerstitial injury score: 3.371.0 vs.
2.010.49; collagen content: 21.82.3 vs. 13.82.4 mg/mg dry tissue;
monocyte/macrophage inﬁltration: 744 vs. 425 cells/mm2; TNF-a:
1.030.22 vs. 0.760.21 pg/mg protein; MCP-1: 10.351.19 vs.
6.000.86 pg/mg protein; p65-NF-kB protein: 545 vs. 363 ng/mg
protein, P<0.05). Blockade of the CCR2 with RS504393 (4 mg/kg) had
no effect on SBP in DOCA-salt-treated WT or TRPV1-/- mice compared
to their respective controls. However, treatment with RS504393
ameliorated renal dysfunction and morphological damage, and pre-
vented the increase in monocyte/macrophage inﬁltration, cytokine/
chemokine production, and NF-kB activity in both DOCA-salt hyper-
tensive strains with a greater effect in DOCA-salt-treated TRPV1-/-
compared to DOCA-salt-treated WT mice.
CONCLUSIONS Our data showed that blockade of CCR2 with
RS504393 attenuated DOCA-salt hypertension-induced renal injury in
WT and TRPV1-/- mice independently of their effects on blood pres-
sure. The protective effect was greater in TRPV1-/- mice compared to
WT mice. The results suggest that deletion of TRPV1 aggravated
salt-sensitive hypertension-induced renal damage possibly via
enhancement of the MCP-1/CCR2-mediated monocyte/macrophage
inﬁltration. [This work was supported by a grant from the National
Natural Science Foundation of China (No. 81170243)].
GW26-e0197
Exploring the Active Ingredients in Chinese Yellow Wine Which Could
Inhibit the Progress of Atherosclerosis in LDLR Knockout Mice
Liping Meng,1,2 Xiaoya Zhai,2 Chenjian Jiang,2 Zheng Ji,2 Yan Guo,2
Jufang Chi,2 Hangyuan Guo1,2
1Shaoxing People’s Hospital; 2The First Clinical Medical College of
Wenzhou Medical University
OBJECTIVES To explore the active ingredients in Chinese yellow
wine which could inhibit the progress of atherosclerosis in LDLR
knockout mice.
